A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
Public ClinicalTrials.gov record NCT06163430. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia
Study identification
- NCT ID
- NCT06163430
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Lead sponsor
- Terns, Inc.
- Industry
- Enrollment
- 180 participants
Conditions and interventions
Interventions
- TERN-701 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 25, 2024
- Primary completion
- Nov 29, 2029
- Completion
- May 30, 2030
- Last update posted
- Jan 11, 2026
2024 – 2030
United States locations
- U.S. sites
- 18
- U.S. states
- 14
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama Medicine (UAB Medicine) | Birmingham | Alabama | 35233 | Recruiting |
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | Recruiting |
| UC Irvine Health | Orange | California | 92868 | Recruiting |
| Rocky Mountain Cancer Centers, LLP | Lone Tree | Colorado | 80303 | Recruiting |
| Florida Cancer Specialists - South Region Research Office | Fort Myers | Florida | 33901 | Not yet recruiting |
| Florida Cancer Affiliates - Ocala | Ocala | Florida | 34474 | Recruiting |
| Florida Cancer Specialists - North Region Research Office | St. Petersburg | Florida | 33705 | Not yet recruiting |
| Florida Cancer Specialists - East Region Research Office | West Palm Beach | Florida | 33401 | Not yet recruiting |
| Georgia Cancer Center at Augusta University | Augusta | Georgia | 30912 | Recruiting |
| Memorial Sloan Kettering Cancer Center - Main Campus | New York | New York | 10065 | Recruiting |
| Atrium Health Levine Cancer Institute | Winston-Salem | North Carolina | 27103 | Recruiting |
| Willamette Valley Cancer Institute and Research Center | Eugene | Oregon | 97401 | Recruiting |
| Oregon Health & Science University | Portland | Oregon | 97239 | Recruiting |
| Thomas Jefferson University - Center City (Philadelphia) | Philadelphia | Pennsylvania | 19107 | Recruiting |
| Tristar BMT | Nashville | Tennessee | 37203 | Recruiting |
| The University of Texas M.D. Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| Huntsman Cancer Institute | Salt Lake City | Utah | 84112 | Recruiting |
| Fred Hutchinson Cancer Center | Seattle | Washington | 98109 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06163430, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 11, 2026 · Synced May 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06163430 live on ClinicalTrials.gov.